Elucidating the mechanism of action of domatinostat (4SC-202) in cutaneous T cell lymphoma cells

Targeting epigenetic modifiers is effective in cutaneous T cell lymphoma (CTCL). However, there is a need for further improvement of this therapeutic approach. Here, we compared the mode of action of romidepsi...

Source: Journal of Hematology and Oncology - March 18, 2019 Category: Hematology Authors: Marion Wobser, Alexandra Weber, Amelie Glunz, Saskia Tauch, Kristina Seitz, Tobias Butelmann, Sonja Hesbacher, Matthias Goebeler, Ren é Bartz, Hella Kohlhof, David Schrama and Roland Houben Tags: Research Source Type: research